BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ding XW, Yan JJ, An P, Lü P, Luo HS. Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines. World J Gastroenterol 2007; 13(8): 1257-1261 [PMID: 17451210 DOI: 10.3748/wjg.v13.i8.1257]
URL: https://www.wjgnet.com/1007-9327/full/v13/i8/1257.htm
Number Citing Articles
1
Ye Chen, Araceli Sánchez, María E. Rubio, Tobias Kohl, Luis A. Pardo, Walter Stühmer, Sven G. Meuth. Functional KV10.1 Channels Localize to the Inner Nuclear MembranePLoS ONE 2011; 6(5): e19257 doi: 10.1371/journal.pone.0019257
2
Xinyu Wu, Zhida Chen, Wengrong Zeng, Yuanfu Zhong, Qingjun Liu, Jin Wu. Silencing ofEag1Gene Inhibits Osteosarcoma Proliferation and Migration by Targeting STAT3-VEGF PathwayBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/617316
3
Thais Torquato Sales, Fernando Francisco Borges Resende, Natália Lemos Chaves, Simoneide Souza Titze-De-Almeida, Sônia Nair Báo, Marcella Lemos Brettas, Ricardo Titze-De-Almeida. Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomideOncology Letters 2016; 12(4): 2581 doi: 10.3892/ol.2016.4992
4
Catherine J. Hutchings, Paul Colussi, Theodore G. Clark. Ion channels as therapeutic antibody targetsmAbs 2019; 11(2): 265 doi: 10.1080/19420862.2018.1548232
5
Huixian Lin, Zhe Li, Chang Chen, Xiaobin Luo, Jiening Xiao, Deli Dong, Yanjie Lu, Baofeng Yang, Zhiguo Wang, Stuart E. Dryer. Transcriptional and Post-Transcriptional Mechanisms for Oncogenic Overexpression of Ether À Go-Go K+ ChannelPLoS ONE 2011; 6(5): e20362 doi: 10.1371/journal.pone.0020362
6
Viren Asher, Heidi Sowter, Robert Shaw, Anish Bali, Raheela Khan. Eag and HERG potassium channels as novel therapeutic targets in cancerWorld Journal of Surgical Oncology 2010; 8(1) doi: 10.1186/1477-7819-8-113
7
Indranil Chattopadhyay, Avninder Singh, Rupkumar Phukan, Joydeep Purkayastha, Amal Kataki, Jagadish Mahanta, Sunita Saxena, Sujala Kapur. Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in IndiaMutation Research/Genetic Toxicology and Environmental Mutagenesis 2010; 696(2): 130 doi: 10.1016/j.mrgentox.2010.01.001
8
Gui-Ming Zhang, Fang-Ning Wan, Xiao-Jian Qin, Da-Long Cao, Hai-Liang Zhang, Yao Zhu, Bo Dai, Guo-Hai Shi, Ding-Wei Ye. Prognostic significance of the TREK-1 K2P potassium channels in prostate cancerOncotarget 2015; 6(21): 18460 doi: 10.18632/oncotarget.3782
9
Ileana Hernandez-Resendiz, Franziska Hartung, Luis A. Pardo. Antibodies Targeting KVPotassium Channels: A Promising Treatment for CancerBioelectricity 2019; 1(3): 180 doi: 10.1089/bioe.2019.0022
10
Dina Cosme, Maria Manuela Estevinho, Florian Rieder, Fernando Magro. Potassium channels in intestinal epithelial cells and their pharmacological modulation: a systematic reviewAmerican Journal of Physiology-Cell Physiology 2021; 320(4): C520 doi: 10.1152/ajpcell.00393.2020
11
Diana Urrego, Naira Movsisyan, Roser Ufartes, Luis A. Pardo. Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cellsCell Cycle 2016; 15(6): 799 doi: 10.1080/15384101.2016.1138187
12
Jessica Iorio, Lisa Lastraioli, Elena Lastraioli. Potassium in Human HealthPhysiology 2022; 12 doi: 10.5772/intechopen.101108
13
Ramón Martínez, Walter Stühmer, Sabine Martin, Julian Schell, Andrea Reichmann, Veit Rohde, Luis Pardo. Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survivalBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1848-y
14
Luis A Pardo, Walter Stühmer. Eag1 as a cancer targetExpert Opinion on Therapeutic Targets 2008; 12(7): 837 doi: 10.1517/14728222.12.7.837
15
Halima Ouadid-Ahidouch, Ahmed Ahidouch, Luis A. Pardo. Kv10.1 K+ channel: from physiology to cancerPflügers Archiv - European Journal of Physiology 2016; 468(5): 751 doi: 10.1007/s00424-015-1784-3
16
Vidhya Rao, Mathew Perez-Neut, Simon Kaja, Saverio Gentile. Voltage-Gated Ion Channels in Cancer Cell ProliferationCancers 2015; 7(2): 849 doi: 10.3390/cancers7020813
17
Lien Moreels, Steve Peigneur, Diogo Galan, Edwin De Pauw, Lászlo Béress, Etienne Waelkens, Luis Pardo, Loïc Quinton, Jan Tytgat. APETx4, a Novel Sea Anemone Toxin and a Modulator of the Cancer-Relevant Potassium Channel KV10.1Marine Drugs 2017; 15(9): 287 doi: 10.3390/md15090287
18
Xiang-Wu Ding, Xiang-Gui Wang, He-Sheng Luo, Shi-Yun Tan, Shan Gao, Bing Luo, Hua Jiang. Expression and Prognostic Roles of Eag1 in Resected Esophageal Squamous Cell CarcinomasDigestive Diseases and Sciences 2008; 53(8): 2039 doi: 10.1007/s10620-007-0116-7
19
T Ishiguro, H Avila, S-Y Lin, T Nakamura, M Yamamoto, D D Boyd. Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastasesBritish Journal of Cancer 2010; 102(4): 774 doi: 10.1038/sj.bjc.6605536
20
Lien Moreels, Steve Peigneur, Yoko Yamaguchi, Kim Vriens, Etienne Waelkens, Shunyi Zhu, Karin Thevissen, Bruno P.A. Cammue, Kazuki Sato, Jan Tytgat. Expanding the pharmacological profile of κ-hefutoxin 1 and analogues: A focus on the inhibitory effect on the oncogenic channel Kv10.1Peptides 2017; 98: 43 doi: 10.1016/j.peptides.2016.08.008
21
Žan Toplak, Louise A. Hendrickx, Reham Abdelaziz, Xiaoyi Shi, Steve Peigneur, Tihomir Tomašič, Jan Tytgat, Lucija Peterlin‐Mašič, Luis A. Pardo. Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatmentMedicinal Research Reviews 2022; 42(1): 183 doi: 10.1002/med.21808
22
Nirakar Sahoo, Kefan Yang, Ina Coburger, Alisa Bernert, Sandip M. Swain, Guido Gessner, Reinhard Kappl, Toni Kühl, Diana Imhof, Toshinori Hoshi, Roland Schönherr, Stefan H. Heinemann. Intracellular hemin is a potent inhibitor of the voltage-gated potassium channel Kv10.1Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18975-2
23
Sarah Williams, Andrew Bateman, Ita O'Kelly, Sven G. Meuth. Altered Expression of Two-Pore Domain Potassium (K2P) Channels in CancerPLoS ONE 2013; 8(10): e74589 doi: 10.1371/journal.pone.0074589
24
Claudia Duranti, Annarosa Arcangeli. Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer DiagnosisAntibodies 2019; 8(2): 33 doi: 10.3390/antib8020033
25
Luis A. Pardo, Walter Stühmer. The roles of K+ channels in cancerNature Reviews Cancer 2014; 14(1): 39 doi: 10.1038/nrc3635
26
A. Innamaa, L. Jackson, V. Asher, G. van Schalkwyk, A. Warren, A. Keightley, D. Hay, A. Bali, H. Sowter, R. Khan. Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancerClinical and Translational Oncology 2013; 15(11): 910 doi: 10.1007/s12094-013-1022-4
27
Qingxuan Lai, Ting Wang, Qingqing Guo, Yuxiang Zhang, Youxin Wang, Li Yuan, Rui Ling, Yan He, Wei Wang. Positive correlation between the expression of hEag1 and HIF-1α in breast cancers: an observational studyBMJ Open 2014; 4(5): e005049 doi: 10.1136/bmjopen-2014-005049
28
Gulimirerouzi Fnu, Georg F. Weber. Alterations of Ion Homeostasis in Cancer Metastasis: Implications for TreatmentFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.765329
29
Nuria Comes, Antonio Serrano-Albarrás, Jesusa Capera, Clara Serrano-Novillo, Enric Condom, Santiago Ramón y Cajal, Joan Carles Ferreres, Antonio Felipe. Involvement of potassium channels in the progression of cancer to a more malignant phenotypeBiochimica et Biophysica Acta (BBA) - Biomembranes 2015; 1848(10): 2477 doi: 10.1016/j.bbamem.2014.12.008
30
Xiang‐Wu Ding, He‐Sheng Luo, Bing Luo, Dong‐Qiang Xu, Shan Gao. Overexpression of hERG1 in resected esophageal squamous cell carcinomas: A marker for poor prognosisJournal of Surgical Oncology 2008; 97(1): 57 doi: 10.1002/jso.20891
31
Hisae Tateishi-Karimata, Keiko Kawauchi, Naoki Sugimoto. Destabilization of DNA G-Quadruplexes by Chemical Environment Changes during Tumor Progression Facilitates TranscriptionJournal of the American Chemical Society 2018; 140(2): 642 doi: 10.1021/jacs.7b09449
32
Zhiguo Wang. Comprehensive Physiology2013; : 599 doi: 10.1002/cphy.c110002
33
Walter Stühmer, Luis A Pardo. K + Channels as Therapeutic Targets in Oncology Future Medicinal Chemistry 2010; 2(5): 745 doi: 10.4155/fmc.10.24
34
Diana Urrego, Adam P. Tomczak, Farrah Zahed, Walter Stühmer, Luis A. Pardo. Potassium channels in cell cycle and cell proliferationPhilosophical Transactions of the Royal Society B: Biological Sciences 2014; 369(1638): 20130094 doi: 10.1098/rstb.2013.0094
35
Heike Wulff, Neil A. Castle, Luis A. Pardo. Voltage-gated potassium channels as therapeutic targetsNature Reviews Drug Discovery 2009; 8(12): 982 doi: 10.1038/nrd2983
36
Joanna Napp, Luis A. Pardo, Franziska Hartung, Lutz F. Tietze, Walter Stühmer, Frauke Alves. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel Kv10.1European Biophysics Journal 2016; 45(7): 721 doi: 10.1007/s00249-016-1152-z